EPIFLO® is the first and only FDA approved therapy which uses a fully portable, 3 ounce device to deliver Oxygen to your patient’s wound 24/7. While other advanced treatment for chronic wounds exist, all have drawbacks which make them undesirable when compared with EPIFLO. Some, such as hyperbaric oxygen (HBOT), often require dozens of visits over a period of months to an enclosed, pressurized chamber for up to three times per week. Others, such as vacuum pump therapy (NPWT) require the patient to be tethered to a heavy pump 24 hours per day, often for months on end. Both of these therapies are akin to stifling a patient’s freedom during the treatment, and often the wound does not heal, resulting in amputation.
NPWT seals the wound air tight and then applies negative pressure to stimulate the healing process. It requires the patient to remain tethered to a pump for the duration of their treatment. Though NPWT is in wide use today, it has serious drawbacks which EPIFLO does not. See this 2011 FDA Consumer Notice on Serious Complications Associated With Negative Pressure Wound Therapy which discloses 12 deaths and 174 injuries to NPWT patients since 2007. Additionally, Ogenix has published many case studies where NPWT failed to close a wound which was later closed using EPIFLO including diabetic foot ulcer with osteomyelitis, heel pressure ulcer, and traumatic foot injury.
Although Hyperbaric Oxygen Therapy is often considered beneficial to the patient, a June, 2011 study shows that HBOT patients who take prescription medications have a 55% chance of suffering a drug interaction while undergoing HBOT. Additionally, the patient must typically travel 4-5 times per week for an appointment that takes two hours. Treatments can go on for months, causing major disruption in the patient’s life. It is also exceedingly expensive when compared with EPIFLO. EPIFLO patients resume their normal lifestyle the moment the EPIFLO device is applied. Because the EPIFLO unit weighs just 3 ounces and sits in your pocket or attaches to your waistband, it is very discreet and typically hidden from view during treatment. Once applied, the patient is free to go about a normal life, whether that includes shopping, dining, or simply going back to work. During the treatment, patients often go for 7-15 days between doctor visits, although increased drainage during the first week is a typical observation and indicates the wound has begun healing.
EPIFLO is disposable, and is replaced with a new unit every 15 days. Recent clinical evidence shows that a 6 month old chronic wound treated with EPIFLO heals in 6-8 weeks. Many heal faster, though some take longer. Many wounds in our database have previously failed hyperbaric or vac pump treatments before being treated with EPIFLO, and most will heal within 7 weeks in spite of failing these other treatments first.
For a risk free trial of EPIFLO, please visit our offer page.